Tuberculosis (TB)

Tuberculosis (TB) is one of the top ten principal causes of death globally. In Bangladesh, which is one of the 30 high TB burden countries and also a high multi-drug-resistant TB(MDR-TB) burden country, the incidence of TB (all forms) is estimated at 225 per 100,000 population per year, and mortality is estimated at 45 per 100,000 population per year. The rate of MDR-TB is 1.6% among new cases and 29% among retreatment cases (3). More than 200,000 TB cases are detected annually; however, around 150,000 cases are still missing, which contributes around 40% of the total estimated TB cases in Bangladesh. RDM is carrying out several implementation research studies that could help identify some of the gaps in TB management and, thereby, support effective program planning and design.

Related studies:

Evaluation of OMNIgene-SPUTUM as sputum stabilizer for transportation to the referral hospital
Costing of National TB plan
Evaluation of Xpert MTB/RIF Ultra for the diagnosis of childhood pulmonary tuberculosis using stool specimen
icddr,b Social Enterprise Model and “Janao” platform to ensure TB care in the private sector of Bangladesh: Investigating the factors associated with diagnostic and treatment delay of TB patients, and assessment of acceptability of “Janao” platform for TB case notification